Depo-Provera Lawsuit: What’s Actually Going On My aunt used the Depo shot for almost a decade in the 2000s. Nobody […]
Depo-Provera Lawsuit: What’s Actually Going On
My aunt used the Depo shot for almost a decade in the 2000s. Nobody in her doctor’s office ever mentioned brain tumors. Neither did the pamphlet. So when she called me last year, rattled after a headache turned into an MRI and the MRI turned into the word “meningioma,” the first thing she asked wasn’t “how do I sue” — it was “wait, this is a known thing now?”
It is. And that’s the entire Depo-Provera lawsuit in one sentence: thousands of women say Pfizer knew, or should have known, that long-term use of this injectable birth control was tied to a real, measurable increase in brain tumor risk — and didn’t warn them.
Here’s the part that surprises people: this isn’t a fringe theory. A large-scale study tracking over 61 million female patient records found women using DMPA (the drug in Depo-Provera) had roughly double the risk of a meningioma diagnosis compared to women not on hormonal birth control. A separate Danish study went further, putting the risk at up to 4.55 times higher for women who’d used the injectable within the past year.
Where the Depo-Provera Lawsuit Stands Right Now (August 2026)
The lawsuits are consolidated into a federal multidistrict litigation, MDL No. 3140, sitting in the Northern District of Florida under Judge M. Casey Rodgers. As of this summer, over 5,800 cases are pending — up from just 78 cases in March 2025. That’s not a typo. It’s one of the fastest-growing pharmaceutical mass torts in the country right now.
The biggest development: in June 2026, Pfizer and plaintiffs’ lead counsel reached a global settlement agreement in principle, formalized with a signed Master Settlement Agreement on July 21, 2026. Pfizer estimates it will resolve claims for roughly 80% of the women currently in the MDL. The terms remain confidential, and no payout amounts or eligibility tiers have been made public yet. The first scheduled bellwether trial (Toney v. Pfizer) had its December 2026 date vacated as a result.
One wrinkle worth knowing: this settlement covers the federal MDL. It does not automatically cover cases filed in state courts like Delaware or New York — those women may need separate legal action.
A Reader’s Story
A woman I’ll call Denise (she asked not to use her real name) used Depo-Provera injections from 2007 to 2014. She didn’t think twice about a headache in 2025 — until imaging found a meningioma and she ended up on an operating table. “I kept using it because it was easy,” she told me. “Nobody ever said ‘brain tumor’ was on the list of things to watch for.” Her story mirrors what’s showing up in court filings across the country: years of quiet use, then a diagnosis that reframes everything in hindsight.
What Symptoms Are Attorneys Flagging
Plaintiffs’ complaints commonly cite: persistent headaches, vision changes, hearing loss, seizures, and cognitive difficulties — all consistent with meningioma symptoms, which often develop slowly and get dismissed as stress or aging.
Frequently Asked Questions
Do I qualify for the Depo-Provera lawsuit? Generally, women who used Depo-Provera (or its generic, medroxyprogesterone acetate) for an extended period and were later diagnosed with a meningioma, at any tumor grade, may qualify. A lawyer can confirm based on your medical records and injection history.
Is Depo-Provera still legal and on the market? Yes. The FDA has not pulled the drug. In December 2025, it approved an updated label that now warns of a potential meningioma link — a change plaintiffs’ attorneys view as significant for the litigation.
How much is the Depo-Provera lawsuit settlement worth? No public payout figures exist yet. Anyone quoting exact settlement amounts online is speculating — the agreement is still confidential.
Is there a deadline to file a Depo-Provera claim? Deadlines depend on your state’s statute of limitations and when you were diagnosed, so don’t wait to ask a lawyer.
Does the settlement cover everyone in the lawsuit? No. It’s expected to resolve about 80% of federal MDL cases; the rest, plus most state-court cases, continue separately.
This article is for informational purposes only and isn’t legal or medical advice. If you’ve used Depo-Provera and have health concerns, talk to a doctor and, separately, a qualified attorney about your options.
